NFKB1 and metabolic syndrome: Moreover, it is notable that inflammatory signaling molecules including relA (NF-κB p65) and MAPK family members [i.e. p44/42 (ERK1/2)] activated in adipose tissue during metabolic syndrome, could trigger metaflammation and insulin resistance [3, 4].